Berne virus possesses haemagglutinating activity which is inhibited by antisera that neutralize the infectivity of the virus. In decreasing order, human, rabbit and guineapig erythrocytes were agglutinated whereas agglutination was not observed with rat, goose, chicken or horse red blood cells. This pattern is different from that seen with the closely related Breda virus of cattle. Haemagglutinin was found to co-sediment with viral infectivity in sucrose density gradients. Transmission electron microscopy showed that intact virus particles form bridges between adjacent erythrocytes. The viral envelope was seen at a distance from the erythrocyte surface suggesting that the peplomers possess haemagglutinating activity. Haemagglutination was decreased in the presence of fetuin and gangliosides and also by pretreatment of the erythrocytes with periodate, suggesting that the virus binds to glycoproteins and/or glycolipids on the erythrocyte surface.
* Haemagglutination inhibition (HI) assays were carried out in U-bottom microtitre plates (Greiner, Niirtingen, F.R.G.). Sera (25 gl) were diluted in twofold steps in PBS and then incubated with 4 HAU of Berne virus (25 gl). To detect haemagglutinin, 50 gl of 0.5~ human O blood group erythrocytes in PBS containing 1% bovine serum albumin was added after incubation of serum with virus for 1 h at room temperature.
t Neutralization assay was as described by Weiss et al. (1984) , using 102 TCIDso of Berne virus.
TCIDso/cell. Forty h post-infection the medium was removed and 100 gl of a 0.05~ (v/v) erythrocyte suspension in saline was incubated with the cells at 4 °C for 20 min. Subsequently the cell monolayers were washed twice with phosphate-buffered saline (PBS). Human (blood group O), rabbit and guinea-pig erythrocytes became bound to the infected cells. In contrast, rat, goose, chicken, mouse, sheep, cattle and horse red cells were negative in this assay.
Haemagglutinin was also detected in supernatants derived from Berne virus-infected cell cultures. A suspension of Berne virus containing 107 TCIDs0/ml agglutinated human, rabbit and guinea-pig erythrocytes with titres of 8, 4 and l, respectively. The specificity of haemagglutination was demonstrated in haemagglutination inhibition (HI) assays using antisera to Berne virus. Horse and rabbit sera with high titres of neutralizing antibody inhibited haemagglutination, whereas low HI titres resulted with sera negative in the neutralization test. Moreover, a monoclonal antibody to Berne virus (I1AID2HI, kindly supplied by Dr B. Kaeffer), inhibited both the infectivity and haemagglutination of Berne virus (Table 1) ; this antibody has been shown to recognize the 75K to 100K glycoprotein in radioimmunoprecipitation .
A supernatant from a Berne virus-infected cell culture containing 8 haemagglutinating units (HAU)/25 gl was concentrated to 128 HAU/25 I.tl by differential centrifugation. This 16-fold concentrated preparation also failed to agglutinate erythrocytes of SIV and Wistar rats. This observation, together with the previous finding that Breda virus does not agglutinate human and guinea-pig erythrocytes (Woode et al., 1982) , clearly shows that the two haemagglutinins differ in their erythrocyte receptor-binding sites.
The pellet obtained after ultracentrifugation contained in addition to concentrated haemagglutinin >99~0 of the infectivity of the original cell culture supernatant. This preparation was subjected to isopycnic centrifugation in a linear 15 to 50~ (w/w) sucrose gradient in a SW41 rotor at 30000 r.p.m, for 5 h. Fig. 1 shows that the position of the haemagglutinin correlated with that of viral infectivity, being at a density of 1.15 to 1.18 g/ml. This result suggests that the haemagglutinin is part of the virus particle.
Additional evidence for this interpretation was obtained by electron microscopy of erythrocyte agglutinates. Fig. 2 shows Berne virus particles bridging two erythrocytes. The viral membrane is seen at a distance of 18 + 3-4 nm (n = 37) from the erythrocyte membrane. Since the unfixed peplomers of Berne virus were shown to measure 20 nm in length in negatively stained preparations (Weiss et al., 1983) this suggests that the haemagglutinating activity is due to the viral spikes formed by the 75K to 100K glycosylated protein .
To characterize the nature of the surface receptor(s) of Berne virus, we investigated the effects of various erythrocyte pretreatment schemes and studied haemagglutination in the presence of inhibitors known to interfere with the binding of influenza viruses to the red cell surface (for review, see B~ichi et al., 1977) . For comparison, influenza A/swine/Germany/2/81 (H1N1) was tested in parallel with Berne virus. As shown in Table 2 haemagglutination was reduced by pretreatment of the erythrocytes with 0.5 mM-periodate and in the presence of bovine brain (11) was as previously described (Weiss et al., 1983) . Agglutinating activity (if]) was measured as described in the text. gangliosides or fetuin. With the exception of fetuin, inhibition was more pronounced with influenza virus than with Berne virus. Neuraminidase pretreatment of the erythrocytes resulted in a 16-fold reduction in agglutination by influenza virus but had no effect on haemagglutination by Berne virus. A wide range of proteolytic enzymes (trypsin, ~-chymotrypsin, papain, proteinases A and K and Pronase E at 0.1 mg/ml) failed to affect haemagglutination by Berne and influenza viruses (results not shown). Taken together, these observations suggest that Berne virus binds to surface structure(s) containing carbohydrates, most likely to glycolipids. * Haemagglutination assays were carried out in U-bottom microtitre plates using PBS as the diluent. Virus was diluted in twofold steps in 25 vl to which 25 gl PBS and 50 ~tl 0.5~ human erythrocytes in PBS containing 1 bovine serum albumin were then added. One haemagglutinating unit is defined as the dilution showing complete agglutination and for ease of comparison is indicated as 100K.
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J" Gangliosides (Sigma, type III) and fetuin (Sigma, type III) were present in the haemagglutination buffer at 0.5 mg/ml and 1.25 mg/ml, respectively.
:~ Erythrocytes were pretreated as described by Armstrong et al. (1984) . Briefly, 0-5 ml of a 5~ erythrocyte suspension was incubated with periodate (final concentration 0.5 mM) for 1 h or with neuraminidase (final concentration 7 units/ml) at 37 °C for 2 h. The cells were then washed twice in Eagle's MEM and suspended in PBS.
However, glycoproteins might also serve as receptors for Berne virus because it cannot be ruled out that glycoproteins were removed incompletely by the proteases, and/or that glycolipids became accessible for binding after removal of glycoproteins. Moreover, due to the limited specificity of the Clostridium perfringens neuraminidase employed in our experiments, neuraminic acid cannot be excluded at present as a carbohydrate constituent of the Berne virus receptor(s).
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